No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs145926736 |
chr12:291441-291442 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS ZNF genes & repeats
|
Chromatin interactive regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs377081128 |
chr12:291442-291443 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS ZNF genes & repeats
|
Chromatin interactive regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs373687935 |
chr12:291450-291451 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS ZNF genes & repeats
|
Chromatin interactive regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs557405619 |
chr12:291455-291456 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS ZNF genes & repeats
|
Chromatin interactive regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs372825444 |
chr12:291468-291469 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS ZNF genes & repeats
|
Chromatin interactive regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs545758155 |
chr12:291491-291492 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS ZNF genes & repeats
|
Chromatin interactive regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs541562792 |
chr12:291498-291499 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS ZNF genes & repeats
|
Chromatin interactive regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs564452112 |
chr12:291515-291516 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS ZNF genes & repeats
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs183359616 |
chr12:291516-291517 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS ZNF genes & repeats
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs369675403 |
chr12:291520-291521 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS ZNF genes & repeats
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs536349568 |
chr12:291525-291526 |
Enhancers Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer Flanking Active TSS ZNF genes & repeats
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs542865578 |
chr12:291617-291618 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs529466927 |
chr12:291668-291669 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs200850407 |
chr12:291712-291713 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs543993002 |
chr12:291715-291716 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs397825804 |
chr12:291716-291717 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs562532778 |
chr12:291738-291739 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs532966467 |
chr12:291739-291740 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs567875701 |
chr12:291780-291781 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs149625104 |
chr12:291809-291810 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs562715430 |
chr12:291819-291820 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs527623488 |
chr12:291822-291823 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs549245749 |
chr12:291832-291833 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs567378500 |
chr12:291842-291843 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs188910973 |
chr12:291905-291906 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs61144307 |
chr12:291910-291911 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
27 |
rs58487822 |
chr12:291934-291935 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs539454239 |
chr12:291986-291987 |
Enhancers Weak transcription Flanking Active TSS Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs76453552 |
chr12:292046-292047 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs546022730 |
chr12:292052-292053 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs564418718 |
chr12:292090-292091 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs144316384 |
chr12:292106-292107 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs578261925 |
chr12:292128-292129 |
Enhancers Weak transcription Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs574871903 |
chr12:292211-292212 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs531906582 |
chr12:292212-292213 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs555995181 |
chr12:292224-292225 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs574165204 |
chr12:292237-292238 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs547748907 |
chr12:292255-292256 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs193243438 |
chr12:292262-292263 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs544748366 |
chr12:292287-292288 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs535911066 |
chr12:292322-292323 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs76758333 |
chr12:292324-292325 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs557335506 |
chr12:292357-292358 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs370850792 |
chr12:292433-292434 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs575506340 |
chr12:292491-292492 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs553705938 |
chr12:292514-292515 |
Enhancers Weak transcription
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs560224026 |
chr12:292534-292535 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs543380927 |
chr12:292547-292548 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs185350467 |
chr12:292548-292549 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs572977478 |
chr12:292558-292559 |
Enhancers Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|